As shown in Figure 1D, SLC25A5‐AS1 level was associated with tumour size (P < 0.01), and lymph node metastasis (P < 0.05) and TNM stage as well (P < 0.05, Table 1), but not associated with sex, ages or histological differentiation, all P > 0.05. Here, SLC25A5 is linked to neoplasm.